Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2026-01-08 @ 11:27 PM
Study NCT ID:
NCT02486133
Status:
COMPLETED
Last Update Posted:
2023-11-29
First Post:
2015-06-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dual Therapy With Boosted Darunavir + Dolutegravir
Sponsor:
Technical University of Munich
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DUA-1463-SPI-0320-I
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None